Kathleen Kox

Title: Kathleen Kox: Innovator in Chemokine Receptor Inhibition

Introduction

Kathleen Kox is a notable inventor based in Bridgewater, NJ (US). She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target chemokine receptors.

Latest Patents

Kathleen Kox holds 1 patent for her invention titled "Piperidinyl piperazine derivatives useful as inhibitors of chemokine receptors." This invention provides a novel class of compounds that serve as inhibitors of the CCR5 receptors. The patent outlines methods for preparing these compounds, pharmaceutical compositions containing them, and their applications in treating various diseases associated with CCR5. These diseases include Human Immunodeficiency Virus (HIV), solid organ transplant rejection, and several inflammatory conditions.

Career Highlights

Kox has had a distinguished career, working with Schering Corporation, where she has been able to apply her innovative ideas in a practical setting. Her work has contributed to advancements in therapeutic options for patients suffering from serious health conditions.

Collaborations

Throughout her career, Kathleen has collaborated with esteemed colleagues such as Tze-Ming Chan and Wenqing Feng. These partnerships have likely enhanced her research and development efforts, leading to impactful innovations in the pharmaceutical industry.

Conclusion

Kathleen Kox's work exemplifies the vital role of inventors in advancing medical science. Her contributions to chemokine receptor inhibition have the potential to improve treatment options for various diseases.